Exosome Treatment for Hair Growth in Male Androgenetic Alopecia

This study is looking into how an injection made from foreskin-derived mesenchymal stromal cells, specifically exosomes, affects hair growth in men with androgenetic alopecia, commonly known as male pattern baldness. It involves 30 male participants aged between 22 and 65 who are experiencing various degrees of hair loss. The main goal is to see if these injections can improve hair density and increase patient satisfaction with their hair. This study is important because it explores a new potential treatment for hair loss, which affects a significant number of men and currently has limited effective options. Participants in the study receive injections of the exosome treatment directly into the scalp areas where hair loss is occurring. Hair density is carefully measured before and after the treatment using digital imaging techniques to ensure accurate results. The measurements are taken initially and then again at 4 and 12 weeks post-treatment. Additionally, participants are asked two questions at these intervals to assess their perception of hair loss reduction and new hair growth. These steps help researchers evaluate the effectiveness of the treatment in both quantitative and qualitative ways, aiming to provide comprehensive insights into how well the exosome treatment works for improving hair growth.